EXAS vs PHR · rev $2.76B vs rev $480.6M
EXACT Sciences Corporation (EXAS) versus Phreesia Inc (PHR) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Phreesia Inc (PHR) is a health information services company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported PHR revenue for 2026-01-31 was $480.6M. Net income was $2.3M. Revenue was up 14.5% from 2025-01-31 to 2026-01-31. PHR currently screens at market cap $1.70B.
EXAS currently screens at market cap $20.03B. PHR currently screens at market cap $1.70B.
Not investment advice. Open the EXAS and PHR stock pages for the full models.
Not investment advice.